Search Results
Search for other papers by Maria P Yavropoulou in
Google Scholar
PubMed
Search for other papers by Marina Tsoli in
Google Scholar
PubMed
Search for other papers by Konstantinos Barkas in
Google Scholar
PubMed
Search for other papers by Gregory Kaltsas in
Google Scholar
PubMed
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK
Search for other papers by Ashley Grossman in
Google Scholar
PubMed
incidentally diagnosed during imaging investigations performed for unrelated purposes (pituitary incidentalomas, PIs) ( Scangas & Laws 2014 ). Recently, pituitary adenomas have been suggested to be renamed pituitary neuroendocrine tumours (pitNETs) ( Asa et al
Search for other papers by Roberto Valente in
Google Scholar
PubMed
Search for other papers by Alastair J Hayes in
Google Scholar
PubMed
Search for other papers by Sven-Petter Haugvik in
Google Scholar
PubMed
Search for other papers by Per Hedenström in
Google Scholar
PubMed
Search for other papers by Darko Siuka in
Google Scholar
PubMed
Search for other papers by Emilie Korsæth in
Google Scholar
PubMed
Search for other papers by Daniel Kämmerer in
Google Scholar
PubMed
Search for other papers by Stuart M Robinson in
Google Scholar
PubMed
Search for other papers by Patrick Maisonneuve in
Google Scholar
PubMed
Search for other papers by Gianfranco Delle Fave in
Google Scholar
PubMed
Search for other papers by Bjorn Lindkvist in
Google Scholar
PubMed
Search for other papers by Gabriele Capurso in
Google Scholar
PubMed
Introduction Pancreatic neuroendocrine neoplasms (PNENs) are a group of tumors which originate from endocrine cells within the pancreas gland. PNENs have heterogeneous clinical behavior owing to their hormone functional status, cellular
Search for other papers by Gregory Kaltsas in
Google Scholar
PubMed
Search for other papers by Ioannis I Androulakis in
Google Scholar
PubMed
Search for other papers by Wouter W de Herder in
Google Scholar
PubMed
Search for other papers by Ashley B Grossman in
Google Scholar
PubMed
L 2003 Paraneoplastic endocrine syndromes: a review . Endocrine Pathology 14 303 – 317 . Deleu D De Geeter F 1991 Neurological manifestations of neuroendocrine neoplasms of the larynx . ORL: Journal for Otorhinolaryngology and its
Search for other papers by Katarina Edfeldt in
Google Scholar
PubMed
Search for other papers by Tanveer Ahmad in
Google Scholar
PubMed
Search for other papers by Göran Åkerström in
Google Scholar
PubMed
Search for other papers by Eva Tiensuu Janson in
Google Scholar
PubMed
Search for other papers by Per Hellman in
Google Scholar
PubMed
Search for other papers by Peter Stålberg in
Google Scholar
PubMed
Search for other papers by Peyman Björklund in
Google Scholar
PubMed
Search for other papers by Gunnar Westin in
Google Scholar
PubMed
intestine, especially in the distal ileum. According to the WHO classification system, from year 2010, SI-NETs are divided into three grades ( Bosman et al . 2010 ); Grade 1 Neuroendocrine neoplasm (Ki67 <3%), Grade 2 Neuroendocrine neoplasm (Ki67 3
Search for other papers by Daniela Molè in
Google Scholar
PubMed
Search for other papers by Teresa Gagliano in
Google Scholar
PubMed
Search for other papers by Erica Gentilin in
Google Scholar
PubMed
Search for other papers by Federico Tagliati in
Google Scholar
PubMed
Search for other papers by Claudio Pasquali in
Google Scholar
PubMed
Search for other papers by Maria Rosaria Ambrosio in
Google Scholar
PubMed
Search for other papers by Giancarlo Pansini in
Google Scholar
PubMed
Search for other papers by Ettore C degli Uberti in
Google Scholar
PubMed
Search for other papers by Maria Chiara Zatelli in
Google Scholar
PubMed
Introduction Pancreatic neuroendocrine neoplasms (PNN) account for <3% of pancreatic tumors ( Ehehalt et al . 2009 ). Current therapy is complete surgical resection ( Fendrich et al . 2006 ), which is however achieved in the minority of cases
Search for other papers by Uriel Clemente-Gutierrez in
Google Scholar
PubMed
Search for other papers by Carolina R C Pieterman in
Google Scholar
PubMed
Search for other papers by Michael S Lui in
Google Scholar
PubMed
Search for other papers by Thomas Szabo Yamashita in
Google Scholar
PubMed
Search for other papers by Andrés Tame-Elorduy in
Google Scholar
PubMed
Search for other papers by Bernice L Huang in
Google Scholar
PubMed
Search for other papers by Aditya S Shirali in
Google Scholar
PubMed
Search for other papers by Derek J Erstad in
Google Scholar
PubMed
Search for other papers by Jeffrey E Lee in
Google Scholar
PubMed
Search for other papers by Sarah B Fisher in
Google Scholar
PubMed
Search for other papers by Paul H Graham in
Google Scholar
PubMed
Search for other papers by Elizabeth G Grubbs in
Google Scholar
PubMed
Search for other papers by Steven G Waguespack in
Google Scholar
PubMed
Search for other papers by Chaan S Ng in
Google Scholar
PubMed
Search for other papers by Nancy Perrier in
Google Scholar
PubMed
nodules showed neoplasm of uncertain malignant potential. Figure 2 Follow-up of nodular adrenal lesions. *Three nodules in two patients (one patient had bilateral neoplasm with uncertain malignant potential). pNET, pancreatic neuroendocrine tumor
Department of Endocrine Oncology, Department of Medical Sciences, University Hospital, Entrance 78, SE-751 85 Uppsala, Sweden
Search for other papers by Kjell Oberg in
Google Scholar
PubMed
classification and the pathology of gastro-entero-pancreatic neuroendocrine neoplasms is discussed by Prof. Günter Klöppel ( Klöppel 2011 ). A number of biomarkers has been developed during the last decades based on development of the immunoassays for various gut
Division of Cancer Sciences, University of Manchester, Manchester, UK
Search for other papers by Mairéad G McNamara in
Google Scholar
PubMed
Université Paris Sud, Faculté de Médecine de Bicêtre, Le Kremlin-Bicêtre, France
Search for other papers by Jean-Yves Scoazec in
Google Scholar
PubMed
Search for other papers by Thomas Walter in
Google Scholar
PubMed
al . 2016 , McNamara et al . 2019 ). There has been recent progress in the pathological diagnosis of high grade neuroendocrine neoplasms (NENs) ( Lloyd et al . 2017 , Rindi et al . 2018 a ) and in the description of their molecular and immune
Search for other papers by Massimo Milione in
Google Scholar
PubMed
Search for other papers by Patrick Maisonneuve in
Google Scholar
PubMed
Search for other papers by Alessio Pellegrinelli in
Google Scholar
PubMed
Search for other papers by Federica Grillo in
Google Scholar
PubMed
Search for other papers by Luca Albarello in
Google Scholar
PubMed
Search for other papers by Paola Spaggiari in
Google Scholar
PubMed
Search for other papers by Alessandro Vanoli in
Google Scholar
PubMed
Search for other papers by Giovanna Tagliabue in
Google Scholar
PubMed
Search for other papers by Eleonora Pisa in
Google Scholar
PubMed
Search for other papers by Luca Messerini in
Google Scholar
PubMed
Clinical Research Lab (CRAB), Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Search for other papers by Giovanni Centonze in
Google Scholar
PubMed
Search for other papers by Frediano Inzani in
Google Scholar
PubMed
Search for other papers by Aldo Scarpa in
Google Scholar
PubMed
Search for other papers by Mauro Papotti in
Google Scholar
PubMed
Search for other papers by Marco Volante in
Google Scholar
PubMed
Search for other papers by Fausto Sessa in
Google Scholar
PubMed
Search for other papers by Nicola Fazio in
Google Scholar
PubMed
University of Milan, School of Medicine, Milan, Italy
Search for other papers by Giancarlo Pruneri in
Google Scholar
PubMed
Search for other papers by Guido Rindi in
Google Scholar
PubMed
Search for other papers by Enrico Solcia in
Google Scholar
PubMed
Search for other papers by Stefano La Rosa in
Google Scholar
PubMed
Search for other papers by Carlo Capella in
Google Scholar
PubMed
Introduction The coexistence of neuroendocrine and non-neuroendocrine components in the same neoplasm is a rare but well-known phenomenon in digestive system tumors. The 2010 World Health Organization (WHO) classification of tumors of the
Search for other papers by Mei Dong in
Google Scholar
PubMed
Search for other papers by James C Yao in
Google Scholar
PubMed
Bronchial carcinoids Bronchial carcinoid (BC), the second most common carcinoid tumor after gastrointestinal carcinoids, accounts for 20–30 percent of all cases of well-differentiated neuroendocrine tumors. With an incidence rate of 1.35 per 1 00